Vudalimab
Based on 1 Customer Validation
Vudalimab (XmAb20717) is a bispecific antibody that binds PD-1 and CTLA-4. Vudalimab preferentially binds to cells co-expressing PD-1 and CTLA-4 and blocks inhibitory checkpoint signaling to promote T cell activation. Vudalimab can be used for research in metastatic castration-resistant prostate cancer (including high-risk disease) and gynecological malignancies.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度 : ≥99.0%
- CAS 番号: 2329669-72-7
- 分子量:144.5 kDa
-
保管条件:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
|
PD-1 |
CTLA-4 |
体外実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
臨床実験
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
アプリケーション
ELISA, FACS, Functional assay
Verified Bioactivity
-
Flow Cytometry analysis of Raji cells labelling CTLA4 (red) with Vudalimab (anti-CTLA4) (HY-P99166). Cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black). -
Flow Cytometry analysis of THP-1 cells labelling PDCD1 (red) with Vudalimab (anti-PDCD1) (HY-P99166). Cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
Product Details
Product Properties
-
性状
Liquid
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
純度
≥99.0%
-
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
-
Storage & Stability
Please store the product under the recommended conditions in the Certificate of Analysis.
-
輸送条件
Shipping with dry ice.
純度とドキュメンテーション
参考文献
ホットトピック
-
All
-
Topics
-
Most Recent
-
Oldest
-
Topics Immune Checkpoint: A Critical Target In Tumor Therapy
Immune checkpoints are inhibitory or costimulatory pathways that regulate T-cell activation, peripheral tolerance, and antitumor immune responses, and tumors can exploit these pathways to restrict effector T-cell function and establish immune escape.
2026-06-18
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Keywords
- Vudalimab
- 2329669-72-7
- XmAb20717
- XmAb 20717
- XmAb-20717
- PD-1/PD-L1
- CTLA-4
- PD-1/Programmed death-ligand 1
- Cytotoxic T-lymphocyte-associated protein 4
- CD152
- PD-1
- RNA signature
- T cell activation
- T cell engraftment
- antitumor activity
- bispecific antibody
- gynecological malignancies
- immune checkpoint
- metastatic castration-resistant prostate cancer
- Inhibitor
- inhibitor
- inhibit